Of the 419 subjects screened, 328 were randomized to a treatment group. In the inhaled insulin group, 1 subject allocated to inhaled insulin was never treated; thus, 327 subjects received the ...

Insulin is a hormone that allows glucose in the blood to enter cells, providing them with the energy to function. A lack of adequate insulin plays a key role in the development of diabetes ...

links between insulin resistance and diabetes, treatment, and complications. Hyperinsulinemia is when insulin levels in the blood are higher than usual. The pancreas makes insulin, a hormone that ...

It is not recommended for the treatment of diabetic ketoacidosis. Do not use during episodes of hypoglycemia or if hypersensitive to insulin glargine or it’s excipients. Patients should be ...

The results of this study provide valuable guidance for both clinicians and patients in selecting the most appropriate therapy for nBCC. Verkouteren BJA et al. Imiquimod cream preceded by superficial ...

Insulin overdose symptoms can include confusion ... They can assist you in seeking a mental health provider and in simplifying your diabetes treatment plan (if that is a cause of depressive feelings).

The regulatory action makes Merilog the first rapid-acting insulin biosimilar to gain FDA approval. According to the federal agency, the approval includes both a prefilled pen and a multi-dose vial, ...

SILVER SPRING, Md., Feb. 14, 2025 /PRNewswire/ -- Today, the U.S. Food and Drug Administration approved Merilog (insulin-aspart-szjj) as biosimilar to Novolog (insulin aspart) for the improvement of ...

Approval of biosimilar products can increase patient access to safe and effective treatment options. "The FDA has now approved three biosimilar insulin products to treat diabetes," said ...

The FDA has approved the first rapid-acting insulin biosimilar product for the treatment of diabetes, according to a press release from the federal agency. With the decision, insulin-aspart-szjj ...

SkinJect Inc. a wholly owned subsidiary of Medicus Pharma Ltd, is a development stage, life sciences company focused on commercializing novel, non-invasive treatment for basal cell skin cancer using ...